SuZhou LaiTeou

    Country: Country China (Mainland)

    Business Type: Trading Company

  • Mr.Billy
    Tel: +86-0512-88957371

  • Mobile:
  • Tel:+86-0512-88957371
  • Fax:
  • Province/state:JIANGSU
  • City:SUZHOU-HUQIU
  • Street:shanghai
  • MaxCard:
Home > Products >  SARMS RAD-140 CAS:1182367-47-0

SARMS RAD-140 CAS:1182367-47-0 CAS NO.1182367-47-0

  • FOB Price: USD: 1.00-11.00 /Metric Ton Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
  • Available Specifications:

    99(1-10)Metric Ton99(1-10)Metric Ton

  • Product Details

Keywords

  • RAD-140
  • 1182367-47-0
  • SARMS

Quick Details

  • ProName: SARMS RAD-140 CAS:1182367-47-0
  • CasNo: 1182367-47-0
  • Molecular Formula: C20H16ClN5O2
  • Appearance: white powder
  • Application: pharmaceutical intermediate
  • DeliveryTime: stocking
  • PackAge: confirms to customer
  • Port: china
  • ProductionCapacity: 1 Kilogram/Day
  • Purity: 99%
  • Storage: shade
  • Transportation: confirms to customer
  • LimitNum: 1 Gram
  • Moisture Content: 0.5%
  • Impurity: 0.1%

Superiority

RAD140, from its internal nonsteroidal selective

androgen receptor modulator (“SARM”) discovery program, for full preclinical development as a

potential therapy for the treatment of age-related muscle loss (sarcopenia) and other

musculoskeletal conditions such as osteoporosis. Radius selected RAD140 from a series of

promising SARMs after it demonstrated exceptional selectivity for anabolic activity in well-

validated in vivo models. Radius expects to complete formal toxicology studies that will allow

 

This makes its usage significantly safer and more effective compared to traditional prohormones and anabolic steroids.

Details

AICAR

2627-69-2

acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown

MK2866

841205-47-8

medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.

MK-677

15972-10-0

A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly

LGD-4033

1165910-22-4

pharmacological profile similar to that of enobosarm, Ostarine,MK-2866

GW501516

317318-70-0

For obesity, diabetes, dyslipidemia and cardiovascular disease

Andarine(S4)

401900-40-0

partial agonist, intended mainly for treatment of benign prostatic hypertrophy

SR9009

1379686-30-2

under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice

SR9011

1379686-30-2

For obesity, diabetes, dyslipidemia and cardiovascular disease

RAD140

1182367-47-0

New generation for gaining mass and cutting edges

YK11

366508-78-3

431579-34-9

a SARM and myostatin inhibitor in one

GHRP-2

158861-67-7

Growth Hormone Releasing Peptide-2

GHRP-6

87616-84-0

Growth Hormone Releasing Peptide-6

TB500

107761-42-2

Thymosin beta 4

SM130,686

/

/

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog